Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» USPTO
USPTO
Seagen patent in Daiichi Sankyo ADC dispute nixed by USPTO News
Pharmaphorum
Wed, 01/17/24 - 09:38 am
Seagen
Daiichi Sankyo
patents
legal
Enhertu
USPTO
At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide
Fierce Pharma
Thu, 10/5/23 - 10:21 am
Viatris
generics
Novo Nordisk
Ozempic
Wegovy
diabetes
patents
USPTO
Pharma IP in view as new USPTO director Kathi Vidal wins Senate confirmation
Endpoints
Wed, 04/6/22 - 07:41 pm
USPTO
patents
Senate
Joe Biden
Kathi Vidal
Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet
Xconomy
Sat, 08/31/19 - 08:00 pm
patents
Alexion
Amgen
biosimilars
USPTO
Biopharma gets better chance to protect patents during inter partes review
BioCentury
Wed, 03/27/19 - 11:33 pm
USPTO
patents
inter partes review
Novartis Challenges USPTO Patent Extension Policy
Forbes
Thu, 07/8/10 - 08:54 am
Novartis
patents
USPTO
Wyeth
vaccines